Kilitch Drugs (India) Ltd
NSE:KILITCH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kilitch Drugs (India) Ltd
NSE:KILITCH
|
IN |
|
China Water Affairs Group Ltd
HKEX:855
|
HK |
|
OceanaGold Corp
TSX:OGC
|
CA |
|
M
|
Magis SpA
MIL:MGS
|
IT |
|
Bukaka Teknik Utama Tbk PT
IDX:BUKK
|
ID |
|
J Sainsbury PLC
LSE:SBRY
|
UK |
|
Naked Wines PLC
LSE:WINE
|
UK |
|
B
|
Bumi Armada Bhd
KLSE:ARMADA
|
MY |
|
Bird Construction Inc
TSX:BDT
|
CA |
|
Badger Infrastructure Solutions Ltd
TSX:BDGI
|
CA |
|
Warby Parker Inc
NYSE:WRBY
|
US |
|
H
|
Hainan Haide Capital Management Co Ltd
SZSE:000567
|
CN |
|
V
|
Venture Global Inc
NYSE:VG
|
US |
|
Fincantieri SpA
MIL:FCT
|
IT |
|
Cyprium Metals Ltd
ASX:CYM
|
AU |
|
T
|
Texwinca Holdings Ltd
HKEX:321
|
HK |
|
W
|
World Houseware (Holdings) Ltd
HKEX:713
|
HK |
|
Z
|
Ziel Home Furnishing Technology Co Ltd
SZSE:301376
|
CN |
|
Lupin Ltd
NSE:LUPIN
|
IN |
|
RH
NYSE:RH
|
US |
Wall Street
Price Targets
KILITCH Price Targets Summary
Kilitch Drugs (India) Ltd
According to Wall Street analysts, the average 1-year price target for KILITCH is 236.64 INR with a low forecast of 234.32 INR and a high forecast of 243.6 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is KILITCH's stock price target?
Price Target
236.64
INR
According to Wall Street analysts, the average 1-year price target for KILITCH is 236.64 INR with a low forecast of 234.32 INR and a high forecast of 243.6 INR.
What is Kilitch Drugs (India) Ltd's Revenue forecast?
Projected CAGR
18%
For the last 13 years the compound annual growth rate for Kilitch Drugs (India) Ltd's revenue is 5%. The projected CAGR for the next 3 years is 18%.
What is Kilitch Drugs (India) Ltd's Operating Income forecast?
Projected CAGR
12%
The compound annual growth rate of Kilitch Drugs (India) Ltd's operating income for the next 3 years is 12%.
What is Kilitch Drugs (India) Ltd's Net Income forecast?
Projected CAGR
7%
For the last 13 years the compound annual growth rate for Kilitch Drugs (India) Ltd's net income is -8%. The projected CAGR for the next 3 years is 7%.
